Skip to content
AnalystLens
Back to MRNAIncome Statement

Moderna, Inc. Revenue 2016-2026 | MRNA

Annual FY2016–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$1.94B

−39.9%YoY vs FY2024Source: 10-KFY2025

From $108.4M in FY2016 to $1.94B in FY2025: 17.9× in 9 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$389M+260.2%Not reportedNot reportedNot reported
FY25$108M−35.3%$142M−41.1%$1.0B−45.4%$678M−29.8%
FY24$167M−91.0%$241M−29.9%$1.9B+1.7%$966M−65.6%
FY23$1.9B−69.3%$344M−92.8%$1.8B−45.6%$2.8B−44.7%
FY22$6.1B+213.2%$4.7B+9.1%$3.4B−32.3%$5.1B−29.5%
Share15%14%33%38%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionDeclining
CAGR

+19.3%

FY2020
$803.0M
FY2025
$1.94B

5 years selected · on the chart

01—History

Revenue History

Year-over-year comparison from 10-K annual reports

  10. $1.94B
YoY changeLargest recent move+2200.2%in FY21Latest −39.9%

2 older moves run past ±150% (largest +2200.2%); point at, tap or drag across the bars to read one.

02—Ledger

Revenue, period by period

PeriodValueChangeSource
FY2025$1.94B−39.9%10-K
FY2024$3.24B−52.7%10-K
FY2023$6.85B−64.4%10-K
FY2022$19.26B+4.3%10-K
FY2021$18.47B+2200.2%10-K
FY2020$803.0M+1238.3%10-K
FY2019$60.0M−55.6%10-K
FY2018$135.1M−34.4%10-K
FY2017$205.8M+89.9%10-K
FY2016$108.4M—10-K

03—Questions

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is Moderna, Inc.'s current revenue?

Moderna, Inc. (MRNA) annual revenue for 2025 was $1.94B, a 39.93% decline from 2024. Moderna, Inc. revenue for the quarter ending March 31, 2026 was $389.0M.

What was Moderna, Inc.'s revenue in 2024?

Moderna, Inc. annual revenue for 2024 was $3.24B, a 52.75% decline from 2023.

What was Moderna, Inc.'s revenue in 2023?

Moderna, Inc. annual revenue for 2023 was $6.85B, a 64.45% decline from 2022.

What is Moderna, Inc.'s 5-year revenue CAGR?

Moderna, Inc. revenue grew at a compound annual growth rate (CAGR) of 19.34% from FY2020 to FY2025, going from $803.0M to $1.94B over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
View company profile →